NHI — National Health Investors Cashflow Statement
0.000.00%
- $3.58bn
- $4.69bn
- $335.18m
- 73
- 54
- 61
- 68
Annual cashflow statement for National Health Investors, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 185 | 112 | 65.5 | 134 | 137 |
| Depreciation | |||||
| Non-Cash Items | -29.6 | 14.5 | 48.1 | -25.9 | -2.46 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.74 | 3.61 | 0.837 | 6.03 | 2.15 |
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 232 | 211 | 185 | 184 | 208 |
| Capital Expenditures | -103 | -46.9 | -6.36 | -41.8 | -142 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 13.2 | 232 | 204 | 30.2 | -50.1 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -89.7 | 185 | 198 | -11.6 | -192 |
| Financing Cash Flow Items | -6.1 | -7.39 | 5.86 | -1.05 | -10.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -112 | -403 | -401 | -170 | -13.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.7 | -6.86 | -18 | 3.1 | 1.89 |